3 Top Dividend Stocks Yielding Up to 8.1%: BIP.UN, D.UN, ENB

If you like sexy tech stocks with fancy buzzwords or exotic mining companies searching for gold in the Congo, then income investing is not for you.
But if you prefer good old-fashioned dividends and are willing to trade being the talk of your next cocktail party for common sense investing, then you’ll like this strategy just fine.
Wonderful companies don’t have to come up with the next gee-whiz gadget every year. They don’t deal in collateralized debt obligations or other financial mumbo-gumbo.
(more)
Please share this article

FireEye Inc (NASDAQ: FEYE)

FireEye, Inc. provides products and services for detecting, preventing, and resolving advanced cybersecurity threats. Its products comprise threat prevention system that provides threat protection from network to endpoint for inbound and outbound network traffic, such as Web threat prevention appliances to analyze all Web traffic; email threat prevention appliances that detect and stop advanced attacks; and file threat prevention appliances, which analyze network file servers to detect and quarantine malicious software.
Take a look at the 1-year chart of FireEye (Nasdaq: FEYE) below with the added notations:

FEYE fell off a cliff after its March peak. However, since bottoming near $25 last May the stock stabilized and has been trading mostly sideways since. The more important thing to note is that FEYE has a key level at $45 (blue) that it has recently broke back above. This should lead to another leg up for the stock.

The Tale of the Tape: FEYE has a key level at $45. A trader could enter a long position on a pullback down to $45 with a stop placed under the level. However, a short trade could be made instead if the stock fails to hold $45.
Please share this article

Danger Signal Now Flashing RED After One Of The Largest Increases In History!

kingworldnews.com / March 01, 2015
Today King World News is pleased to share a fantastic piece that warns a major danger signal is now flashing RED after one of the largest increases in history!  This piece also includes a key illustration that all KWN readers around the world must see.
By Jason Goepfert Founder & CEO Of SentimenTrader 
March 1 (King World News) – We’ve discussed in previous reports over the past two years how traders in volatility products have tended to be the smart money, at least to the best of our limited knowledge in how they are using the products.
The three main exchange-traded funds based on the VIX “fear gauge” (VXX, UVXY and TVIX) have seen their shares outstanding ebb and flow over the past three years based on demand from traders.

READ MORE
Please share this article

Man Who Predicted Collapse Of Euro Against Swiss Franc Warns Of Next Shock To The World

kingworldnews.com / March 01, 2015
Today the man who 90 days ago remarkably predicted the collapse of the euro against the Swiss franc warned King World News about the next shock that will bring the world to its knees.
Egon von Greyerz:  “Eric, it’s now totally clear to me that the hyperinflation I’ve been expecting is becoming more persistent and is now engulfing country after country.  We are already seeing it in the periphery but it’s on its way to engulfing the developed countries of the world….
Hyperinflation Is A Currency Event
Hyperinflation is a currency event.  It arises as a result of countries living above their means for a protracted period of time.  This causes massive debts and eventual money printing.

READ MORE

Please share this article

US Weekly Economic Calendar

time (et)	report	period	ACTUAL	forecast	previous
MONDAY, MARCH 2
8:30 am	Personal income	Jan.		0.4%	0.3%
8:30 am	Consumer spending	Jan.		-0.1%	-0.3%
8:30 am	Core inflation	Jan.		0.1%	0.0%
9:45 am	Markit PMI	Feb.		--	54.3
10 am	ISM	Feb.		52.8%	53.5%
10 am	Construction spending	Jan.		0.3%	0.4%
TUESDAY,  MARCH 3
TBA	Motor vehicle sales	Feb.		16.7 mln	16.6 mln
WEDNESDAY, march 4
8:15 am	ADP employment	Feb.		--	213,000
10 am	ISM nonmanufacturing	Feb.		55.9%	56.7%
2 pm	Beige book
THURSDAY, march 5
8:30 am	Weekly jobless claims	Feb. 28		301,000	313,000
8:30 am	Productivity	4Q		-2.2%	-1.8%
8:30 am	Unit labor costs	4Q		3.2%	2.7%
10 am	Factory orders	Jan.		-0.3%	-3.4%
FRIDAY, march 6
8:30 am	Nonfarm payrolls	Feb.		238,000	257,000
8:30 am	Unemployment rate	Feb.		5.6%	5.7%
8:30 am	Average hourly earnings	Feb.		0.2%	0.5%
8:30 am	Trade deficit	Jan.		-$40.6 bln	-$46.6 bln
3 pm	Consumer credit	Jan.		--	$15 bln

Please share this article

Regulus Therapeutics Inc (NASDAQ: RGLS)

Regulus Therapeutics Inc., a biopharmaceutical company, focuses on the discovery and development of drugs that target microRNAs for the treatment of various diseases in the United States. The company uses its microRNA product platform to develop anti-miRs, which is chemically modified and single-stranded oligonucleotide. The company has strategic collaboration with Biogen Idec MA Inc. for the evaluation of the use of microRNA signatures as a biomarker for human patients with multiple sclerosis; AstraZeneca AB to discover and develop microRNA therapeutics for cardiovascular diseases, metabolic diseases, and oncology; and GlaxoSmithKline plc to discover and develop microRNA therapeutics for immuno-inflammatory diseases. It also has strategic collaboration with Sanofi for the discovery and development of microRNA therapeutics comprising miR-21 pre-clinical fibrosis program for the treatment of alport syndrome and preclinical program for oncology indications.
Take a look at the 1-year chart of Regulus (Nasdaq: RGLS) below with my added notations:

RGLS had steadily went nowhere from April until mid-October. Then, the stock jumped massively on route to hitting a new high just above $25. Since that time, the stock has created an obvious resistance at $20 (green). A break above that $20 level should mean higher prices for the stock.

The Tale of the Tape: RGLS has a key level of resistance at $20. A long trade could be entered on a break through that level. However, if you are bearish on the stock, a short trade could be made on any rallies up to $20.
Please share this article

Is Rob McEwen Looking To Buy?

Please share this article